New diabetes clinical trial: Comparison of Different Insulin Dosing Algorithms Using Hepatic Directed Vesicle-Insulin Lispro and Insulin Degludec

Published on: May 06, 2019 at 09:30PM
Condition:   Diabetes Mellitus, Type 1
Interventions:   Drug: HDV-Insulin Lispro and Insulin Degludec (-40%);   Drug: HDV-Insulin Lispro and Insulin Degludec (-10%)
Sponsor:   Diasome Pharmaceuticals
Recruiting
http://bit.ly/2H4dh7i